A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia

Pierre François Laterre*, Steven M. Opal, Edward Abraham, Steven P. LaRosa, Abla A. Creasey, Fang Xie, Lona Poole, Richard G. Wunderink

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia'. Together they form a unique fingerprint.

Medicine & Life Sciences